DUBLIN, April 1, 2021 /PRNewswire/ -- The "Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type; Product; Technology; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. It is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.

The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.

Chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, are the leading causes of death and disability worldwide. As per the Centers for Disease Control and Prevention (CDC), in 2019, nearly 6 in 10 people suffered from at least one chronic disease in the US. Cardiovascular diseases (CVDs) are a significant cause of mortality owing to the hectic lifestyle. As per the World Health Organization (WHO), CVDs are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Cancer is among the leading causes of mortality worldwide, and the disease affects a huge population; therefore, it acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is positively affecting the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis Kymriah is used to treat diffuse large B-cell lymphoma. The launches of more such products would be driving the demand for cell therapy, thus driving the growth of the cell therapy market in the coming years.

The COVID-19 outbreak was first reported in Wuhan (China) in December 2019. The pandemic is causing massive disruptions in supply chains, consumer markets, and economy across the world. As the healthcare sector is focusing on saving lives of COVID-19 patients, the demand for cell therapy is reducing worldwide.

Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited; JCR Pharmaceuticals Co. Ltd.; Smith & Nephew; Bristol-Myers Squibb Company; Cells for Cells; Stemedica Cell Technologies, Inc; and Castle Creek Biosciences, Inc. are among the companies operating in the cell therapy market.

Reasons to Buy

Key Topics Covered:

1. Introduction 1.1 Scope of the Study 1.2 Research Report Guidance 1.3 Market Segmentation 1.3.1 Global Cell Therapy Market - By Therapy Type 1.3.2 Global Cell Therapy Market - By Product 1.3.3 Global Cell Therapy Market - By Technology 1.3.4 Global Cell Therapy Market - By Application 1.3.5 Global Cell Therapy Market - By End User 1.3.6 Global Cell Therapy Market - By Geography

2. Cell Therapy Market - Key Takeaways

3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research

4. Global Cell therapy- Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America - PEST Analysis 4.2.2 Europe- PEST Analysis 4.2.3 Asia Pacific- PEST Analysis 4.2.4 Middle East and Africa - PEST Analysis 4.2.5 South and Central America - PEST Analysis 4.3 Expert Opinions

5. Global Cell Therapy Market - Key Industry Dynamics 5.1 Key Market Drivers 5.1.1 Increasing Prevalence of Chronic Diseases 5.1.2 Rising Adoption of Regenerative Medicines 5.1.3 Increasing Number of Approvals for Cell-Based Therapies 5.2 Key Market Restraints 5.2.1 High Cost of Cell Therapy Manufacturing 5.3 Key Market Opportunities 5.3.1 Increasing Adoption of Cell Therapy in Developing Regions 5.4 Future Trends 5.4.1 Shift Toward Automated Cell Therapy Manufacturing 5.5 Impact Analysis of Drivers and Restraints

6. Cell therapy Market - Global Analysis 6.1 Global Cell therapy Market Revenue Forecast And Analysis 6.2 Global Cell therapy Market, By Geography - Forecast And Analysis 6.3 Market Positioning

7. Cell therapy Market Analysis - By Therapy Type 7.1 Overview 7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027) 7.3 Allogeneic 7.3.1 Overview 7.3.2 Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 7.4 Autologous 7.4.1 Overview 7.4.2 Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Cell therapy Market Analysis - By Product 8.1 Overview 8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027) 8.3 Consumables 8.3.1 Overview 8.3.2 Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 8.4 Equipment 8.4.1 Overview 8.4.2 Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 8.5 Systems and Software 8.5.1 Overview 8.5.2 Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Cell therapy Market Analysis - By Technology 9.1 Overview 9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027) 9.3 Viral Vector Technology 9.3.1 Overview 9.3.2 Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.4 Genome Editing Technology 9.4.1 Overview 9.4.2 Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.5 Somatic Cell Technology 9.5.1 Overview 9.5.2 Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.6 Cell Immortalization Technology 9.6.1 Overview 9.6.2 Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.7 Cell Plasticity Technology 9.7.1 Overview 9.7.2 Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 9.8 Three-Dimensional Technology 9.8.1 Overview 9.8.2 Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Cell therapy Market Analysis - By Application 10.1 Overview 10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027) 10.3 Oncology 10.3.1 Overview 10.3.2 Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.4 Cardiovascular 10.4.1 Overview 10.4.2 Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.5 Orthopedic 10.5.1 Overview 10.5.2 Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.6 Wound Management 10.6.1 Overview 10.6.2 Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 10.7 Other Applications 10.7.1 Overview 10.7.2 Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Cell therapy Market Analysis - By End User 11.1 Overview 11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%) 11.3 Hospitals 11.3.1 Overview 11.3.2 Hospitals: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 11.4 Research Institutes 11.4.1 Overview 11.4.2 Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million) 11.5 Others 11.5.1 Overview 11.5.2 Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

12. Cell therapy Market - Geographic Analysis 12.1 North America: Cell Therapy Market 12.2 Europe: Cell therapy Market 12.3 Asia Pacific: Cell Therapy Market 12.4 Middle East and Africa: Cell Therapy Market 12.5 South and Central America: Cell Therapy Market

13. Impact of COVID-19 Pandemic on Global Cell Therapy Market 13.1 North America: Impact Assessment of COVID-19 Pandemic 13.2 Europe: Impact Assessment of COVID-19 Pandemic 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic 13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic 13.5 South & Central America: Impact Assessment of COVID-19 Pandemic

14. Cell Therapy Market- Industry Landscape 14.1 Overview 14.2 Growth Strategies Done by the Companies in the Market, (%) 14.3 Organic Developments 14.3.1 Overview 14.4 Inorganic Developments 14.4.1 Overview

15. Company Profiles 15.1 Vericel Corporation 15.1.1 Key Facts 15.1.2 Business Description 15.1.3 Products and Services 15.1.4 Financial Overview 15.1.5 SWOT Analysis 15.1.6 Key Developments 15.2 MEDIPOST 15.2.1 Key Facts 15.2.2 Business Description 15.2.3 Products and Services 15.2.4 Financial Overview 15.2.5 SWOT Analysis 15.2.6 Key Developments 15.3 NuVasive, Inc. 15.3.1 Key Facts 15.3.2 Business Description 15.3.3 Products and Services 15.3.4 Financial Overview 15.3.5 SWOT Analysis 15.3.6 Key Developments 15.4 Mesoblast Limited 15.4.1 Key Facts 15.4.2 Business Description 15.4.3 Products and Services 15.4.4 Financial Overview 15.4.5 SWOT Analysis 15.4.6 Key Developments 15.5 JCR Pharmaceuticals Co. Ltd. 15.5.1 Key Facts 15.5.2 Business Description 15.5.3 Products and Services 15.5.4 Financial Overview 15.5.5 SWOT Analysis 15.5.6 Key Developments 15.6 Smith & Nephew 15.6.1 Key Facts 15.6.2 Business Description 15.6.3 Products and Services 15.6.4 Financial Overview 15.6.5 SWOT Analysis 15.6.6 Key Developments 15.7 Bristol-Myers Squibb Company 15.7.1 Key Facts 15.7.2 Business Description 15.7.3 Products and Services 15.7.4 Financial Overview 15.7.5 SWOT Analysis 15.7.6 Key Developments 15.8 Cells for Cells 15.8.1 Key Facts 15.8.2 Business Description 15.8.3 Products and Services 15.8.4 Financial Overview 15.8.5 SWOT Analysis 15.8.6 Key Developments 15.9 Stemedica Cell Technologies, Inc 15.9.1 Key Facts 15.9.2 Business Description 15.9.3 Products and Services 15.9.4 Financial Overview 15.9.5 SWOT Analysis 15.9.6 Key Developments 15.10 Castle Creek Biosciences, Inc. 15.10.1 Key Facts 15.10.2 Business Description 15.10.3 Products and Services 15.10.4 Financial Overview 15.10.5 SWOT Analysis 15.10.6 Key Developments

16. Appendix 16.1 About the Publisher 16.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/hxk6k0

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Excerpt from:
Worldwide Cell Therapy Industry to 2027 - Increasing Prevalence of Chronic Diseases is Driving the Market - PRNewswire